In partnership with @lustgarten.org & @theaacr.bsky.social, we are funding Wolpin’s work using daraxonrasib for early detection & interception of pancreatic cancer—because the ultimate goal isn’t just extending life; it’s restoring cancer-free futures.
themarkfoundation.org/portfolio/de...
Pancreatic ductal adenocarcinoma is the third leading cause of cancer-related death in the United States, largely because most patients are diagnosed only after the disease has reached an advanced…
